Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,745,060
+$410,884 QoQ
Shares Held
197,054
+27.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#619
of 2,821 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$24,080
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HUB Investment Partners, LLC holds $120,989,044 across 14 Drug Manufacturers - General names. PFE ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
158,806 | $39,961,941 | |
| 2 | JNJ |
Johnson & Johnson
|
72,119 | $18,316,062 | |
| 3 | LLY |
ELI LILLY & Co
|
14,924 | $17,900,294 | |
| 4 | AZN |
Astrazeneca PLC
|
78,626 | $14,909,062 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
87,005 | $10,992,211 | |
| 6 | MRK |
Merck & Co., Inc.
|
51,940 | $6,674,290 | |
| 7 | PFE |
Pfizer Inc
This page
|
197,054 | $4,745,060 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,485 | $2,275,125 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,080 | 1,000 | Call | Sole | 2026-07-31 | |
| 2026-06-30 | $4,745,060 | 197,054 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $28,080 | 1,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $4,334,176 | 154,351 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,653,128 | 146,712 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $24,900 | 1,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $3,240,291 | 127,170 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,480,406 | 102,327 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,784,721 | 70,431 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,875,034 | 70,676 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,133,543 | 73,723 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,143,967 | 76,625 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,931,400 | 69,600 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,229,620 | 42,710 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $546,144 | 16,465 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $3,317 | 100 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $345,195 | 9,411 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $454,267 | 11,134 | Shares | Sole | 2023-04-24 | |
| 2022-09-30 | $486,830 | 11,125 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $328,683 | 6,269 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $321,647 | 6,213 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $484,918 | 8,212 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $744,546 | 17,311 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $775,172 | 19,795 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $782,097 | 21,587 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $615,168 | 16,712 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||